© 2012 Landes Bioscience. Do not distribute. The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)

Keywords: Neisseria meningitidis, vaccine, adverse drug event, Haemophilus influenzae type bAbbreviations: AE, adverse event; BD CI, confidence interval; DTaP–HepB–IPV, diphtheria-tetanus-acellularpertussis-hepatitis B-inactivated poliovirus vaccine; ER, emergency room; Hib, Haemophilus influenzae type b;HibMenCY, Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine;FDA, Food and Drug Administration; ACIP, Advisory Committee on Immunization Practices; MedDRA, Medical Dictionary forRegulatory Activities; MenC, monovalent meningococcal serogroup C conjugate vaccine; MMR, measles-mumps-rubella vaccine;PCV7, 7-valent pneumococcal conjugate vaccine; RR, relative risk; SAE, serious adverse event; TT, tetanus toxoid; VAR, varicella vaccine